XFZ-11490-98288
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Headache, Fatigue or tirednessFree text: Runny nose and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-05
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous — Feeling: GoodFree text: MiscarriageMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-21
-
2022-04-22
Survey response — 12 months, dose 2MedDRA: Dry skin, Eczema — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eczema, dry skinMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-22 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose and sore throat
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose
Release 9 — 3 months, dose 2
Symptoms: Miscarriage
Release 11 — 12 months, dose 2
Symptoms: Eczema, dry skin
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | Dry skin | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release